PROMETHERA BIOSCIENCES
A bankruptcy procedure is open for PROMETHERA BIOSCIENCES according to publications in the Belgian State Gazette. The file additionally contains 4 judicial reorganisations. The 2022 annual accounts show negative equity (€-1.50M) and a net result of €-520k.
| Equity | €-1.50M |
| Net result | €-520k |
| Better than sector | 5% |
| Active | 17 yrs |
Fragile profile, watch health in particular.
Bankruptcy opened
A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -34.5% | 51.3% | |
| Net result | €-520k | €40k | |
| Equity | €-1.50M | €98k | |
| Gross operating margin | €55k | €110k | |
| Staff costs | €-1k | €220k |
| Fiscal year | 2022 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €-520k |
| Cash flow | - |
| Staff costs | €-1k |
| Income taxes | - |
| Dividends | - |
| Total assets | €4.34M |
| Equity | €-1.50M |
| Debt | €5.84M |
| of which ≤ 1y | €2.44M |
| of which > 1y | €3.39M |
| Working capital | €1.83M |
| Employees (FTE) | - |
| 2022 | |
|---|---|
| Current ratio | 1.75 |
| Quick ratio | 1.75 |
| Working capital ratio | 42.3% |
| Solvency | -34.5% |
| Debt / equity | -3.90 |
| Long-term debt ratio | -2.27 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -12.0% |
| ROE | 34.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €4.34M |
| Fixed assets | 21/28 | €64k |
| Financial fixed assets | 28 | €64k |
| Current assets | 29/58 | €4.28M |
| Amounts receivable within one year | 40/41 | €4k |
| Cash & bank | 54/58 | €611 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €4.34M |
| Equity | 10/15 | €-1.50M |
| Contributions / capital | 10/11 | €61.71M |
| Reserves | 13 | €17.09M |
| Accumulated profits (losses) | 14 | €-80.29M |
| Amounts payable | 17/49 | €5.84M |
| Amounts payable after one year | 17 | €3.39M |
| Amounts payable within one year | 42/48 | €2.44M |
| Trade debts payable within one year | 44 | €1.58M |
| Income statement | ||
| Gross operating margin | 9900 | €55k |
| Operating result | 9901 | €-500k |
| Financial charges | 65 | €20k |
| Result before taxes | 9903 | €-520k |
| Net result for the period | 9904 | €-520k |
| Result to be appropriated | 9905 | €-455k |
| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | RODOLPHE DE SAN RUE DE CLAIRVAUX 40,
1348 LOUVAIN-LA-NEUVE |
27-05-2024 → present | Belgian State Gazette |
| NACE primary | Human health(86995) |
| Legal form | Public limited company(014) |
| Incorporation | 12-02-2009 |
| Status | Active |
| Postal code | 1435 |
| First BS signal | 18-12-2020 |
| Latest BS signal | 31-05-2024 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonia | 6.2 ha | 1 · 17 m² | 7.8 m · 2 fl. |
| 52028B0323/00M003 | Wallonia | 8,679 m² | 1 · 791 m² | 18.8 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-05-2022 1 director appointed, 3 resigning
- Bruno De Keersmaeker, Bestuurder
- Eric Fok, Bestuurder
- Alain Parthoens, Bestuurder
- Reiko Namikawa, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Eric Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Bruno De Keersmaeker",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}23-02-2022 1 director appointed, 1 resigning
- Didier Delanoye, Commissaire
- Zimeng Dong, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}09-02-2022 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-01-28",
"act_kind_objet": "CESSION DE BRANCHE D\u0027ACTIVITES"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2022-01-17",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0809.788.365",
"name": "PROMETHERA BIOSCIENCES",
"role": "contributor",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0764.522.425",
"name": "Promethera Therapeutics",
"role": "recipient",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103",
"12:93",
"12:94",
"12:95",
"12:97",
"12:98",
"12:99",
"12:100"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2021-02-23",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La cession concerne une branche d\u0027activit\u00E9 au sens de l\u0027article 12:11 du Code des soci\u00E9t\u00E9s et des associations, comprenant l\u0027ensemble des actifs (y compris les cr\u00E9ances), passifs, droits et obligations aff\u00E9rents aux \u00E9l\u00E9ments d\u00E9crits \u00E0 l\u0027annexe 1 du Projet Commun de Cession. Cette branche est technique et organisationnellement autonome, et peut fonctionner de mani\u00E8re ind\u00E9pendante.",
"equity_transferred_eur": null,
"accounting_effective_date": "2021-03-30"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null
},
"summary_narrative": "La soci\u00E9t\u00E9 anonyme PROMETHERA BIOSCIENCES a c\u00E9d\u00E9 \u00E0 titre on\u00E9reux, \u00E0 la soci\u00E9t\u00E9 anonyme Promethera Therapeutics, une branche d\u0027activit\u00E9 constitu\u00E9e d\u0027actifs, passifs, droits et obligations li\u00E9s \u00E0 une activit\u00E9 autonome, conform\u00E9ment aux dispositions de l\u0027article 12:103 du Code des soci\u00E9t\u00E9s et des associations. Le transfert a \u00E9t\u00E9 effectu\u00E9 \u00E0 compter du 30 mars 2021, et les op\u00E9rations relatives \u00E0 cette branche sont comptabilis\u00E9es comme si elles avaient \u00E9t\u00E9 r\u00E9alis\u00E9es par la soci\u00E9t\u00E9 b\u00E9n\u00E9ficiaire.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte"
],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}10-11-2020 5 directors appointed, 2 resigning
- Etienne Sokal, Dagelijks bestuur
- A Q Invest SRL, Dagelijks bestuur
- Alain Parthoens, Dagelijks bestuur
- Alick Dong, Dagelijks bestuur
- Etienne Sokal, Président du conseil d'administration
- Silver Ocean Ventures SAS, Administrateur, administrateur délégué
- Charles Dimmler, Administrateur, président du conseil d'administration
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur, administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Silver Ocean Ventures SAS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alick Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur, pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Charles Dimmler",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-09-2020 3 directors appointed
- Zimeng Dong, Bestuurder
- Chi Tak Fok, Bestuurder
- A Q Invest SRL, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Chi Tak Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-09-2020 Masaki Doi resigns as administrateur indépendant
- Masaki Doi, Administrateur indépendant
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur ind\u00E9pendant",
"person": {
"rrn": null,
"name": "Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}22-06-2020 1 director appointed, 1 resigning
- Shintaro Hayashi, Bestuurder
- Tajio Enoki, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Shintaro Hayashi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-02-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}09-01-2020 Capital increase of €3,318,312.22 to €20,318,312.22
- €17.000.000 → €20.318.312,22
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 20318312.22,
"delta_eur": 3318312.219999999,
"before_eur": 17000000.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-12-2019 Capital increase of €338,246.60 to €19,977,982.14
- €19.639.735,54 → €19.977.982,14
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19977982.14,
"delta_eur": 338246.6000000015,
"before_eur": 19639735.54,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-12-2019 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-11-2019 Capital increase of €135,112.50 to €19,639,735.54
- €19.504.623,04 → €19.639.735,54
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19639735.54,
"delta_eur": 135112.5,
"before_eur": 19504623.04,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-09-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-05-2019 Capital increase of €11,311,354.92 to €19,449,363.08
- €8.138.008,16 → €19.449.363,08
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19449363.08,
"delta_eur": 11311354.919999998,
"before_eur": 8138008.16,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-04-2019 1 director appointed, 1 resigning
- Tetsuya Kurihara, Bestuurder
- Kinji Fuchikami, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Kinji Fuchikami",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tetsuya Kurihara",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}19-02-2019 Tajio Enoki appointed as director
- Tajio Enoki, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}10-01-2019 Capital increase of €54,281.25 to €10,760,883.85
- €10.706.602,60 → €10.760.883,85
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10760883.85,
"delta_eur": 54281.25,
"before_eur": 10706602.6,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}07-12-2018 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-11-2018 BDO ATRIO Réviseurs d'entreprises appointed as auditor
- BDO ATRIO Réviseurs d'entreprises, Auditor
Technical details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "BDO ATRIO R\u00E9viseurs d\u0027entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "Promethera Biosciences"
}
}23-08-2018 Capital increase of €52,687.50 to €10,706,602.60
- €10.653.915,10 → €10.706.602,60
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10706602.6,
"delta_eur": 52687.5,
"before_eur": 10653915.1,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-07-2018 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}08-06-2018 Capital increase of €1,153.53 to €10,653,915.10
- €10.652.761,57 → €10.653.915,10
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10653915.1,
"delta_eur": 1153.5299999993294,
"before_eur": 10652761.57,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-05-2018 Capital increase of €1,033,579.39 to €10,652,761.57
- €9.619.182,18 → €10.652.761,57
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10652761.57,
"delta_eur": 1033579.3900000006,
"before_eur": 9619182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}03-05-2018 Capital increase of €8,735,000 to €9,619,182.18
- €884.182,18 → €9.619.182,18
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9619182.18,
"delta_eur": 8735000.0,
"before_eur": 884182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}16-03-2018 3 directors appointed, 3 resigning
- Madame Reiko Namikawa, Bestuurder
- Monsieur Charles L. Dimmier III, Bestuurder
- Monsieur Masaki Doi, Bestuurder
- Sparaxis SA, Bestuurder
- Madame Ilka Wicke, Bestuurder
- Monsieur Jean-Paul Prieels, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sparaxis SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Ilka Wicke",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Jean-Paul Prieels",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Charles L. Dimmier III",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}12-10-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}01-09-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}21-06-2017 Capital increase of €112,162.50 to €8,841,873.44
- €8.729.710,94 → €8.841.873,44
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8841873.44,
"delta_eur": 112162.5,
"before_eur": 8729710.94,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}04-01-2017 Capital increase of €0.01 to €8,729,710.94
- €8.729.710,93 → €8.729.710,94
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8729710.94,
"delta_eur": 0.009999999776482582,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-11-2016 Capital increase of €990.99 to €8,730,701.92
- €8.729.710,93 → €8.730.701,92
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8730701.92,
"delta_eur": 990.9900000002235,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PROMETHERA BIOSCIENCES |